| Control | DAN− | DAN+PH− | DAN+PH+ |
Subjects M:F | 9:1 | 8:0 | 7:0 | 8:1 |
Age yrs | 42.0 (36.3–47.7) | 45.3 (35.3–55.2) | 45.3 (35.7–54.8) | 48.0 (41.2–54.3) |
BMI kg·m−2 | 24.4 (23.0–25.0) | 24.8 (23.1–25.7) | 24.0 (19.8–26.3) | 24.1 (22.0–26.0) |
Diabetic autonomic neuropathy score | | 0.3 (0.0–0.6) | 4.3 (3.9–5.2)*** | 7.4 (6.6–8.5)***,# |
Glycaemia mg·dL−1 at 23:00 h# | | 167 (121–213) | 176 (124–228) | 208 (155–260) |
Glycaemia mg·dL−1 at 06:30 h# | | 139 (123–154) | 163 (127–199) | 170 (131–204) |
Total sleep time min | 399 (332–469) | 370 (299–411) | 370 (299–441) | 384 (321–448) |
REM sleep % | 20 (16–24) | 17 (14–18) | 19 (17–22) | 19 (16–23) |
Latency min | 21 (8–35) | 15 (3–27) | 18 (7–29) | 17 (6–28) |
Wake after sleep onset min | 37 (15–61) | 39 (18–59) | 55 (28–80) | 48 (29–67) |
Macroarousals n | 5.1 (3.2–7.9) | 6.5 (4.4–8.6) | 7.6 (3.4–11.8) | 6.6 (3.7–9.4) |
Microarousals events·h−1 | 1.1 (0.3–1.9) | 1.3 (–0.1–2.2) | 7.3 (3.8–11.1)* | 8.9 (2.7–12.2) |
AI events·h−1 | 0.2 (−0.2–1.1) | 0.3 (−0.2–0.9) | 3.7 (−1.9–9.4) | 3.3 (0.2–6.5) |
AHI events·h−1 | 2.2 (−0.1–4.1) | 2.8 (0.1–5.5) | 8.1 (−1.9–18.1) | 11.1 (3.3–19.0)* |
ODI events·h−1 | 0.3 (−0.8–1.1) | 1.2 (−0.1–2.4) | 6.5 (−1.5–14.6)* | 7.8 (1.4–14.2)* |
Subjects with Sa,O2 <90% during NREM n | 0 | 0 | 4 | 3 |
Subjects with Sa,O2 <90% during REM n | 0 | 0 | 5 | 5 |